Verena Materna

Overexpression of cMOAT (MRP2/ABCC2) Is Associated with Decreased Formation of Platinum-DNA Adducts and Decreased G2-Arrest in Melanoma Cells Resistant to Cisplatin

Bernd Liedert, Verena Materna, Dirk Schadendorf et al. · Journal of Investigative Dermatology · 2003 · 126 citations

Medicine, Molecular Biology, Oncology +13

ABCC2 (MRP2, cMOAT) Can Be Localized in the Nuclear Membrane of Ovarian Carcinomas and Correlates with Resistance to Cisplatin and Clinical Outcome

Paweł Surowiak, Verena Materna, Irina Kaplenko et al. · Clinical Cancer Research · 2006 · 104 citations

Medicine, Gynecology, Oncology +17

Occurence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor.

Paweł Surowiak, Dawid Murawa, Verena Materna et al. · PubMed · 2007 · 97 citations

Medicine, Oncology, Pathology +17

Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients

Paweł Surowiak, Verena Materna, Irina Kaplenko et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2005 · 96 citations

Medicine, Cancer Biology, Oncology +17

Protection of platinum–DNA adduct formation and reversal of cisplatin resistance by anti‐MRP2 hammerhead ribozymes in human cancer cells

Verena Materna, Bernd Liedert, Jürgen Thomale et al. · International Journal of Cancer · 2005 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17